DHTKD1
2-oxoadipate dehydrogenase complex component E1
Also known as: CMT2Q, DHTK1_HUMAN, DKFZP762M115, KIAA1630, MGC3090
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96HY7
- Gene
- DHTKD1
- Ensembl
- ENSG00000181192
- Chromosome
- 10
- Canonical length
- 919 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a component of a mitochondrial 2-oxoglutarate-dehydrogenase-complex-like protein involved in the degradation pathways of several amino acids, including lysine. Mutations in this gene are associated with 2-aminoadipic 2-oxoadipic aciduria and Charcot-Marie-Tooth Disease Type 2Q. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
919 residues, UniProt reviewed canonical sequence.
>Q96HY7|DHTKD1
1 MASATAAAAR RGLGRALPLF WRGYQTERGV YGYRPRKPES REPQGALERP PVDHGLARLV
61 TVYCEHGHKA AKINPLFTGQ ALLENVPEIQ ALVQTLQGPF HTAGLLNMGK EEASLEEVLV
121 YLNQIYCGQI SIETSQLQSQ DEKDWFAKRF EELQKETFTT EERKHLSKLM LESQEFDHFL
181 ATKFSTVKRY GGEGAESMMG FFHELLKMSA YSGITDVIIG MPHRGRLNLL TGLLQFPPEL
241 MFRKMRGLSE FPENFSATGD VLSHLTSSVD LYFGAHHPLH VTMLPNPSHL EAVNPVAVGK
301 TRGRQQSRQD GDYSPDNSAQ PGDRVICLQV HGDASFCGQG IVPETFTLSN LPHFRIGGSV
361 HLIVNNQLGY TTPAERGRSS LYCSDIGKLV GCAIIHVNGD SPEEVVRATR LAFEYQRQFR
421 KDVIIDLLCY RQWGHNELDE PFYTNPIMYK IIRARKSIPD TYAEHLIAGG LMTQEEVSEI
481 KSSYYAKLND HLNNMAHYRP PALNLQAHWQ GLAQPEAQIT TWSTGVPLDL LRFVGMKSVE
541 VPRELQMHSH LLKTHVQSRM EKMMDGIKLD WATAEALALG SLLAQGFNVR LSGQDVGRGT
601 FSQRHAIVVC QETDDTYIPL NHMDPNQKGF LEVSNSPLSE EAVLGFEYGM SIESPKLLPL
661 WEAQFGDFFN GAQIIFDTFI SGGEAKWLLQ SGIVILLPHG YDGAGPDHSS CRIERFLQMC
721 DSAEEGVDGD TVNMFVVHPT TPAQYFHLLR RQMVRNFRKP LIVASPKMLL RLPAAVSTLQ
781 EMAPGTTFNP VIGDSSVDPK KVKTLVFCSG KHFYSLVKQR ESLGAKKHDF AIIRVEELCP
841 FPLDSLQQEM SKYKHVKDHI WSQEEPQNMG PWSFVSPRFE KQLACKLRLV GRPPLPVPAV
901 GIGTVHLHQH EDILAKTFALocalizationUniProt · AlphaFold · HPA
Whether an antibody against DHTKD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 121 nTPM
Expression across tissuesHPA
Tissue
- liver: 121 nTPM
- kidney: 40 nTPM
- tongue: 22 nTPM
- skeletal muscle: 18 nTPM
- pancreas: 17 nTPM
- heart muscle: 12 nTPM
Single-cell type
- hepatocytes: 401 nCPM
- proximal tubule cells: 180 nCPM
- neutrophils: 96 nCPM
- prostatic glandular cells: 95 nCPM
- cholangiocytes: 64 nCPM
- microglia: 61 nCPM
Immune cell
- basophil: 24 nTPM
- neutrophil: 20 nTPM
- plasmacytoid DC: 17 nTPM
- non-classical monocyte: 17 nTPM
- eosinophil: 16 nTPM
- NK-cell: 15 nTPM
Brain region
- cerebellum: 32 nTPM
- choroid plexus: 30 nTPM
- white matter: 28 nTPM
- basal ganglia: 27 nTPM
- medulla oblongata: 26 nTPM
- thalamus: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DHTKD1.
Disease | AllUniProt
Conditions DHTKD1 is implicated in, by any mechanism.
- Charcot-Marie-Tooth disease, axonal, type 2Q (CMT2Q) MIM:615025
- Alpha-aminoadipic and alpha-ketoadipic aciduria (AAKAD) MIM:204750
Disease | GeneticClinVar
61 pathogenic / likely-pathogenic of 1,057 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- 2-aminoadipic 2-oxoadipic aciduria
- Charcot-Marie-Tooth disease axonal type 2Q
- DHTKD1-related disorder
- Charcot-Marie-Tooth disease type 2A2
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.12
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- generation of precursor metabolites and energy
- glycolytic process
- hematopoietic progenitor cell differentiation
Molecular functions
- thiamine pyrophosphate binding
- 2-oxoadipate dehydrogenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dehydrogenase, E1 component
- Transketolase-like, pyrimidine-binding domain
- 2-oxoglutarate dehydrogenase E1 component
- Thiamin diphosphate-binding fold
- 2-oxoglutarate dehydrogenase E1 component/KDG, C-terminal
- Multifunctional 2-oxoglutarate metabolism enzyme, C-terminal domain superfamily
- Dehydrogenase E1 component
- Transketolase, pyrimidine binding domain
- 2-oxoglutarate dehydrogenase C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DHTKD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DHTKD1 as an antibody target. Whether an autoantibody or antibody against DHTKD1 could matter depends on whether native DHTKD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DHTKD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DHTKD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...